Novarad Receives Indonesian Approval for VisAR Surgical System

Novarad has received approval from the Indonesian Food and Drug Administration (FDA) for its VisAR surgical navigation system.

Designed to use augmented reality, the system is intended for intraoperative use in stereotactic spine surgery.

The surgical navigation system is accurate for both open and minimally invasive surgery.

Novarad’s comprehensive solution consists of preoperative planning, segmentation, virtual annotation and two-way image connection.

Surgeons will use this technology to convert patient image data into 3D holograms that can be accurately projected onto the patient’s body.

This allows the surgeon to focus completely on the surgical objective without distraction from another monitor, ensuring accurate surgical guidance.

The system also provides integrated 2D and 3D immersive navigation views and continuous hologram and patient registration.

Furthermore, pedicle screw placement accuracy in open and minimally invasive surgery is less than 2mm.

VisAR facilitates seamless set-up, allowing surgeons to access the entire operating room footprint using voice-controlled commands.

The system uses advanced technology that leverages CT fiducial markers displayed on medical images for automatic registration.

Novarad and Microsoft have teamed up to use pre-built AR headset technology, allowing them to reduce costs and take advantage of future hardware advancements.

Physicians wear the wireless Microsoft HoloLens 2 visor via VisAR, eliminating the need for additional navigation equipment.

Dr. Wendell Gibby, CEO of Novarad and co-creator of VisAR, said: “FDA approval of VisAR in Indonesia is a testament to its innovative design and ability to improve patient outcomes.

“This technology will enable Indonesian surgeons to perform complex surgeries with greater precision and less risk, ultimately benefiting patients.”

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *